Search results
Parkinson’s patient moves freely again after world-first implant of lab-grown cells into his brain
Euronews via Yahoo News· 5 days agoParkinson’s patient Thomas Matsson was the first in the world to receive 7 million lab-grown brain...
Rytary interactions: Other medications, alcohol, and more
Medical News Today· 3 days ago) is a brand-name oral capsule prescribed for Parkinson’s disease and parkinsonism. Rytary has...
Magic City Newsmakers: Prosper, Iron Tribe, Kiwanis Club, Nature Conservancy and more - Birmingham...
The Business Journals· 8 hours agoThe World Literacy Foundation is seeking nominations for young people aged 15 to 25 in Birmingham to...
California Assemblymember Laura Friedman Announces Bill to Ban Lethal Agricultural Spray, Paraquat,...
Sierra Sun Times· 4 days agoWhile farmers use a range of pesticides and herbicides, easily the most toxic herbicide still in use...
Earnings call: Anavex Life Sciences eyes Alzheimer's, Rett syndrome trials By Investing.com
Investing.com· 3 days agoAnavex Life Sciences Corp. (NASDAQ:AVXL) held its fiscal 2024 second-quarter earnings call,...
IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of...
Digital Journal· 7 days agoIRL757 is being developed as a treatment to...
Elderly Phillies Fan Allegedly Scammed Out of $50,000 by Man Impersonating Trea Turner
Sports Illustrated· 3 days agoIn two years with the Philadelphia Phillies, shortstop Trea Turner has evolved into a beloved figure...
As Ozzy Osbourne announces stem cell therapy, experts urge caution, highlight risks
Fox News· 4 days ago"The thing is, you have it, and you go, ‘I don't feel that great,’ but I don't know what it would be...
Therapeutic target identified to neutralize toxic forms of Parkinson's-associated protein
Medical Xpress· 7 days agoAlpha-synuclein aggregation is a hallmark of Parkinson's disease and other synucleinopathies. It is a dynamic process in which the protein ...
Earnings call: Ventyx Biosciences reports promising Phase 1 results By Investing.com
Investing.com· 7 hours agoVentyx Biosciences, in their first quarter 2024 earnings call, announced positive outcomes from the...